|
GLE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.056020E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.638900E-03 |
| Normal-vs-Stage2 |
5.151600E-01 |
| Normal-vs-Stage3 |
8.228000E-01 |
| Normal-vs-Stage4 |
1.154100E-04 |
| Stage1-vs-Stage2 |
2.072000E-01 |
| Stage1-vs-Stage3 |
2.233400E-01 |
| Stage1-vs-Stage4 |
9.871600E-02 |
| Stage2-vs-Stage3 |
8.507000E-01 |
| Stage2-vs-Stage4 |
2.881600E-02 |
| Stage3-vs-Stage4 |
4.354000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.238480E-02 |
| Normal-vs-AfricanAmerican |
6.276000E-02 |
| Normal-vs-Asian |
2.126400E-01 |
| Caucasian-vs-AfricanAmerican |
9.910600E-01 |
| Caucasian-vs-Asian |
4.355400E-01 |
| AfricanAmerican-vs-Asian |
3.903200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.021700E-04 |
| Normal-vs-Female |
9.334200E-01 |
| Male-vs-Female |
2.719900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.697600E-02 |
| Normal-vs-Extreme_Weight |
1.242050E-04 |
| Normal-vs-Obese |
4.264400E-01 |
| Normal-vs-Extreme_Obese |
1.084810E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.653600E-01 |
| Normal_Weight-vs-Obese |
4.193000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.009200E-01 |
| Extreme_Weight-vs-Obese |
6.427700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.287600E-01 |
| Obese-vs-Extreme_Obese |
4.240600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.953600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.961800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.003840E-03 |
| Normal-vs-Age(81-100Yrs) |
2.651400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.030000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.626600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.978400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.986100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.017800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.109800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.736700E-03 |
| Normal-VS-Type2 PRCC |
2.634600E-01 |
| Normal-VS-KIRP CIMP |
6.441800E-01 |
| Normal-VS-Unclassified PRCC |
7.208400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.800200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.254800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.325400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.803400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.477800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.926200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.423960E-01 |
| Normal-vs-N1 |
8.464800E-01 |
| Normal-vs-N2 |
1.432050E-01 |
| N0-vs-N1 |
4.687000E-01 |
| N0-vs-N2 |
2.878600E-01 |
| N1-vs-N2 |
2.032000E-01 |
|
|
